OUR VISION:  A world in which every child with Progeria is cured

OUR MISSION: To discover treatments and the cure for Hutchinson-Gilford Progeria Syndrome
and its aging-related disorders, including heart disease.

Get Involved

zach superman small

Today, over 80 children from 30 countries are enrolled in a PRF-funded drug trial. Because of your support, the children are receiving the benefits of lonafarnib: stronger hearts and longer lives.

About PRF

Sammy-Basso- in USA

Your donation helps The Progeria Research Foundation treat children with Progeria today, and cure them in the future.

 

News

  • OnePossible_PRFside

June 1st, 2018|0 Comments

August 1: PRF’s 2018 ONEpossible Campaign Exceeds its Goal!  

A huge THANK YOU to the over 1,000 PRF donors who helped us raise $159,000! All funds from our annual summer campaign go directly to our vital clinical trials. We thank each and every ONE of you for making a cure POSSIBLE.
  • Eiger

May 15th, 2018|0 Comments

May 16, 2018: On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib.  

Collaboration marks first therapy submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial. Click here for more details.
  • ZachHPFE

April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!

April 24th, 2018|0 Comments

A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Click here for more details.